Your browser doesn't support javascript.
Nanotechnology Enabled Solutions to Combat Covid-19: Prevention, Treatment, and Diagnosis.
Musyuni, Pankaj; Nagpal, Manju; Singh, Manjinder; Goyal, Ramesh K; Aggarwal, Geeta.
  • Musyuni P; Delhi Pharmaceutical Sciences and Research University, New Delhi-110017,India.
  • Nagpal M; Chitkara College of Pharmacy, Chitkara University, Punjab,India.
  • Singh M; Chitkara College of Pharmacy, Chitkara University, Punjab,India.
  • Goyal RK; Delhi Pharmaceutical Sciences and Research University, New Delhi-110017,India.
  • Aggarwal G; Delhi Pharmaceutical Sciences and Research University, New Delhi-110017,India.
Curr Pharm Biotechnol ; 23(1): 98-111, 2022.
Article in English | MEDLINE | ID: covidwho-1043364
ABSTRACT
Changes in human lifestyles and environmental deterioration globally cause the emergence of new viruses, posing research challenges. The outburst of COVID-19 (nCoV19) is a recent example, wherein effective management of virus, using the conventional medication and effective diagnostic measures is a challenge. While many ongoing strategies from vaccine development to drug repurposing are currently being investigated, a targeted approach with nanotechnology can be helpful to meet the demand for preventive and diagnostic measures. The significant results of nanotechnology in providing better efficacy of pharmaceutical drugs is expected to combat nCoV19 by using nanotechnology- based solutions, preventive treatment, and diagnosis. This article addresses the dire need for nanotechnology-based solutions in the current pandemic, as well as analyzes the ongoing innovation and existing patents that can be used to provide better solutions. Multiple applications of nanotechnology are considered to be helpful in preventive and diagnostic measures, immune response modulation, and immunity boosters, along with projecting a pathway for industry and academic researchers for addressing such a pandemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Curr Pharm Biotechnol Journal subject: Biotechnology / Pharmacology Year: 2022 Document Type: Article Affiliation country: 1389201022666210122124311

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Curr Pharm Biotechnol Journal subject: Biotechnology / Pharmacology Year: 2022 Document Type: Article Affiliation country: 1389201022666210122124311